EU OKs Roche's Avastin for ovarian cancer
December 23, 2011 — ZURICH (Reuters) - The European Commission has approved Roche's drug Avastin for treating women with newly diagnosed, advanced ovarian cancer, offering new options to sufferers previously limited to surgery and chemotherapy.
Better ovarian cancer screening, still no answers
November 29, 2011 — NEW YORK (Reuters Health) - After disappointing results earlier this year, researchers say new study findings from Kentucky offer a bit of hope for ovarian cancer screening.
Scientists find new ovarian cancer gene
August 8, 2011 — LONDON (Reuters) - Women who carry a faulty copy of a gene called RAD51D have an almost one in 11 chance of developing ovarian cancer, scientists said on Sunday in a finding they called the most significant ovarian cancer gene discovery for more than 10 years.
Select news items provided by Reuters Health